Gleeson discusses JAKPPPOT data showing the therapy met all feasibility thresholds with a markedly larger response than historic placebo in PPP.
David Gleeson, BM BCH, PhD
Advertisement
Dermatology registrar at St John's Institute of Dermatology and NIHR academic clinical fellow at King's College London.
Articles by David Gleeson, BM BCH, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
US Alcohol Use Falls, but Not for Adults Aged 50 to 64, With Brian Lee, MD
2
EASD 2026: EloraTZP Bests Tirzepatide on Weight Loss, A1C in Type 2 Diabetes
3
Nail Detachment 4 Times More Common With GLP-1 Use
4
FDA Approves Mavacamten for Pediatric Patients With Obstructive HCM
5